Moderna Inc (MRNA) — Free Cash Flow Generation Index
Moderna Inc (MRNA) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of $912.00 Million represents 1% of operating cash flow ($951.00 Million). Explore MRNA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Moderna Inc Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for Moderna Inc across 4 annual periods. For the full cash flow conversion analysis, see MRNA cash generation efficiency.
Annual Free Cash Flow Generation for Moderna Inc (2016–2022)
Year-by-year Free Cash Flow Generation Index for Moderna Inc. Check Moderna Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.92x | $4.58 Billion | $4.98 Billion | $400.00 Million | ▼ -6.1% |
| 2021 | 0.98x | $13.34 Billion | $13.62 Billion | $284.00 Million | ▲ +1.3% |
| 2020 | 0.97x | $1.96 Billion | $2.03 Billion | $67.45 Million | ▲ +92.1% |
| 2016 | 0.50x | $33.59 Million | $66.73 Million | $33.14 Million | — |